{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:15:02Z","timestamp":1790158502182,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,5,29]],"date-time":"2003-05-29T00:00:00Z","timestamp":1054166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/s00277-003-0679-0","type":"journal-article","created":{"date-parts":[[2003,10,27]],"date-time":"2003-10-27T19:08:56Z","timestamp":1067281736000},"page":"500-505","source":"Crossref","is-referenced-by-count":58,"title":["CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease"],"prefix":"10.1007","volume":"82","author":[{"given":"J.","family":"Barretina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Junc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Est\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,5,29]]},"reference":[{"key":"679_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/oxfordjournals.annonc.a059151","volume":"6","author":"Montserrat","year":"1995","unstructured":"Montserrat E, Rozman C (1995) Chronic lymphocytic leukemia: present status. Ann Oncol 6:219-235","journal-title":"Ann Oncol"},{"key":"679_CR2","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","volume":"94","author":"Burger","year":"1999","unstructured":"Burger JA, Burger M, Kipps TJ (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94:3658-3667","journal-title":"Blood"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","volume":"13","author":"Mohle","year":"1999","unstructured":"Mohle R, Failenschmid C, Bautz F, Kanz L (1999) Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 13:1954-1959","journal-title":"Leukemia"},{"key":"679_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.leu.2402107","volume":"15","author":"Durig","year":"2001","unstructured":"Durig J, Schmucker U, Duhrsen U (2001) Differential expression of chemokine receptors in B cell malignancies. Leukemia 15:752-756","journal-title":"Leukemia"},{"key":"679_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56","journal-title":"Nature"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0301-472X(01)00741-X","volume":"29","author":"Shen","year":"2001","unstructured":"Shen W, Bendall LJ, Gottlieb DJ, Bradstock KF (2001) The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp Hematol 29:1439-1447","journal-title":"Exp Hematol"},{"key":"679_CR7","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood.V91.7.2387","volume":"91","author":"Lagneaux","year":"1998","unstructured":"Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P (1998) Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 91:2387-2396","journal-title":"Blood"},{"key":"679_CR8","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","volume":"96","author":"Burger","year":"2000","unstructured":"Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96:2655-2663","journal-title":"Blood"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","volume":"99","author":"Tsukada","year":"2002","unstructured":"Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ (2002) Distinctive features of \"nurselike\" cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99:1030-1037","journal-title":"Blood"},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G, et al. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206","journal-title":"Cancer"},{"key":"679_CR11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V64.3.642.642","volume":"64","author":"Rozman","year":"1984","unstructured":"Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. (1984) Bone marrow histologic pattern\u2014the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642-648","journal-title":"Blood"},{"key":"679_CR12","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.161.6.3195","volume":"161","author":"Ostrowski","year":"1998","unstructured":"Ostrowski MA, Justement SJ, Catanzaro A, et al. (1998) Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 161:3195-3201","journal-title":"J Immunol"},{"key":"679_CR13","doi-asserted-by":"publisher","first-page":"10319","DOI":"10.1128\/JVI.75.21.10319-10325.2001","volume":"75","author":"Llano","year":"2001","unstructured":"Llano A, Barretina J, Gutierrez A, et al. (2001) Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 75:10319-10325","journal-title":"J Virol"},{"key":"679_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","volume":"108","author":"Moreau","year":"1997","unstructured":"Moreau EJ, Matutes E, A'Hern RP, et al. (1997) Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol 108:378-382","journal-title":"Am J Clin Pathol"},{"key":"679_CR15","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/00002030-200109280-00023","volume":"15","author":"Llano","year":"2001","unstructured":"Llano A, Barretina J, Blanco J, Gutierrez A, Clotet B, Este JA (2001) Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo. AIDS 15:1890-1892","journal-title":"AIDS"},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1089\/088922299310359","volume":"15","author":"Derdeyn","year":"1999","unstructured":"Derdeyn CA, Costello C, Kilby JM, et al. (1999) Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals. AIDS Res Hum Retroviruses 15:1063-1071","journal-title":"AIDS Res Hum Retroviruses"},{"key":"679_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/75022","volume":"6","author":"Poznansky","year":"2000","unstructured":"Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT (2000) Active movement of T cells away from a chemokine. Nat Med 6:543-548","journal-title":"Nat Med"},{"key":"679_CR18","doi-asserted-by":"crossref","first-page":"362a","DOI":"10.1182\/blood.V96.1.362","volume":"96","author":"Lagneaux","year":"2000","unstructured":"Lagneaux L, Delforge A, Massy M, Bernier M, Bron D (2000) Increased production of SDF-1 by bone marrow (BM) stromal cells (SC) derived from chronic lymphocytic leukemia (CLL) patients in comparison with normal subjects: role in the migration of CLL B cells. Blood 96:362a","journal-title":"Blood"},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1155\/2000\/28085","volume":"7","author":"Ivanoff","year":"2000","unstructured":"Ivanoff J, Ivanoff A, Sundqvist KG (2000) Defective chemokine production in T-leukemia cell lines and its possible functional role. Dev Immunol 7:67-75","journal-title":"Dev Immunol"},{"key":"679_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/cyto.1996.0012","volume":"8","author":"von","year":"1996","unstructured":"von Luettichau I, Nelson PJ, Pattison JM, et al. (1996) RANTES chemokine expression in diseased and normal human tissues. Cytokine 8:89-98","journal-title":"Cytokine"},{"key":"679_CR21","first-page":"25","volume":"5","author":"Appasamy","year":"1999","unstructured":"Appasamy PM (1999) Biological and clinical implications of interleukin-7 and lymphopoiesis. Cytokines Cell Mol Ther 5:25-39","journal-title":"Cytokines Cell Mol Ther"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood.V97.10.2983","volume":"97","author":"Fry","year":"2001","unstructured":"Fry TJ, Connick E, Falloon J, et al. (2001) A potential role for interleukin-7 in T-cell homeostasis. Blood 97:2983-2990","journal-title":"Blood"},{"key":"679_CR23","first-page":"561","volume":"87","author":"E Montserrat","year":"2002","unstructured":"Montserrat E (2002) Prognosis in chronic lymphocytic leukemia: let's have a look! Haematologica 87:561-562","journal-title":"Haematologica"},{"key":"679_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234","journal-title":"Blood"},{"key":"679_CR25","unstructured":"Binet JL (1999) Prognostic factors in chronic lymphocytic leukaemia. Haematologica 84 [Suppl EHA-4]:96-97"},{"key":"679_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1468-0734.2000.00003.x","volume":"4","author":"Stilgenbauer","year":"2000","unstructured":"Stilgenbauer S, Lichter P, Dohner H (2000) Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol 4:48-72","journal-title":"Rev Clin Exp Hematol"},{"key":"679_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, et al. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99:1023-1029","journal-title":"Blood"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/1040-8428(94)00150-R","volume":"20","author":"Moore","year":"1995","unstructured":"Moore JS, Friedman DF, Silberstein LE, Besa EC, Nowell PC (1995) Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia. Crit Rev Oncol Hematol 20:141-164","journal-title":"Crit Rev Oncol Hematol"},{"key":"679_CR29","first-page":"42","volume":"25","author":"Zwiebel","year":"1998","unstructured":"Zwiebel JA, Cheson BD (1998) Chronic lymphocytic leukemia: staging and prognostic factors. Semin Oncol 25:42-59","journal-title":"Semin Oncol"},{"key":"679_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/10428190290011921","volume":"43","author":"Burger","year":"2002","unstructured":"Burger JA, Kipps TJ (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk Lymphoma 43:461-466","journal-title":"Leuk Lymphoma"},{"key":"679_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C","volume":"91","author":"Stratowa","year":"2001","unstructured":"Stratowa C, Loffler G, Lichter P, et al. (2001) CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 91:474-480","journal-title":"Int J Cancer"},{"key":"679_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.283.5403.845","volume":"283","author":"Peled","year":"1999","unstructured":"Peled A, Petit I, Kollet O, et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science 283:845-848","journal-title":"Science"},{"key":"679_CR33","first-page":"17","volume":"17","author":"Petit","year":"2002","unstructured":"Petit I, Szyper-Kravitz M, Nagler A, et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 17:17","journal-title":"Nat Immunol"},{"key":"679_CR34","unstructured":"Van Os R, Schols D, Struyf S, De Clercq E, Willemze R, Fibbe WE (2000) The CXCR4 receptor antagonist AMD3100 does not prevent homing and engraftment of murine syngeneic bone marrow stem cells (abstract). The American Society of Hematology 42nd Annual Meeting, San Francisco, CA, December 1\u20135, 2000"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/89490","volume":"4","author":"Bezzi","year":"2001","unstructured":"Bezzi P, Domercq M, Brambilla L, et al. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710","journal-title":"Nat Neurosci"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1182\/blood.V99.4.1117","volume":"99","author":"Lataillade","year":"2002","unstructured":"Lataillade JJ, Clay D, Bourin P, et al. (2002) Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)\/G(1) transition in CD34(+) cells: evidence for an autocrine\/paracrine mechanism. Blood 99:1117-1129","journal-title":"Blood"},{"key":"679_CR37","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.4049\/jimmunol.167.6.3064","volume":"167","author":"Suzuki","year":"2001","unstructured":"Suzuki Y, Rahman M, Mitsuya H (2001) Diverse transcriptional response of CD4(+) T cells to stromal cell- derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 167:3064-3073","journal-title":"J Immunol"},{"key":"679_CR38","doi-asserted-by":"publisher","first-page":"23916","DOI":"10.1074\/jbc.274.34.23916","volume":"274","author":"Amara","year":"1999","unstructured":"Amara A, Lorthioir O, Valenzuela A, et al. (1999) Stromal cell-derived factor-1 alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 274:23916-23925","journal-title":"J Biol Chem"},{"key":"679_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/AAC.44.1.51-56.2000","volume":"44","author":"Blanco","year":"2000","unstructured":"Blanco J, Barretina J, Henson G, et al. (2000) The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface- expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob Agents Chemother 44:51-56","journal-title":"Antimicrob Agents Chemother"},{"key":"679_CR40","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/00002030-199905280-00006","volume":"13","author":"Blanco","year":"1999","unstructured":"Blanco J, Jacotot E, Cabrera C, et al. (1999) The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling. AIDS 13:909-917","journal-title":"AIDS"},{"key":"679_CR41","first-page":"3106","volume":"62","author":"Bertolini","year":"2002","unstructured":"Bertolini F, Dell'Agnola C, Mancuso P, et al. (2002) CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 62:3106-3112","journal-title":"Cancer Res"},{"key":"679_CR42","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1182\/blood-2002-01-0248","volume":"100","author":"Honczarenko","year":"2002","unstructured":"Honczarenko M, Le Y, Glodek AM, et al. (2002) CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 100:2321-2329","journal-title":"Blood"},{"key":"679_CR43","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1182\/blood-2002-03-0938","volume":"100","author":"Ishibe","year":"2002","unstructured":"Ishibe N, Albitar M, Jilani IB, Goldin LR, Marti GE, Caporaso NE (2002) CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood 100:1100-1101","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0679-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-003-0679-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0679-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0679-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:06:51Z","timestamp":1682582811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-003-0679-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,29]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s00277-003-0679-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,29]]}}}